Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men
- PMID: 12324291
- DOI: 10.1093/ajcn/76.4.780
Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men
Abstract
Background: Stimulation of energy expenditure (EE) with selective thermogenic beta-adrenergic agonists may be a promising approach for treating obesity.
Objective: We analyzed the effects of the highly selective human beta(3)-adrenergic agonist L-796568 on 24-h EE, substrate oxidation, and body composition in obese, weight-stable men.
Design: In this 2-center, double-blind, randomized, parallel-group study, we measured 24-h EE before and after 28 d of treatment with L-796568 (375 mg/d) or placebo during weight maintenance (ie, without dietary intervention) in nondiabetic, nonsmoking men aged 25-49 y with body mass index (in kg/m(2)) of 28-35 (n = 10 subjects per treatment group).
Results: The mean change in 24-h EE from before to after treatment did not differ significantly between groups (92 +/- 586 and 86 +/- 512 kJ/24 h for the L-796568 and placebo groups, respectively). The change in 24-h nonprotein respiratory quotient from before to after treatment did not differ significantly between groups (0.009 +/- 0.021 and 0.009 +/- 0.029, respectively). No changes in glucose tolerance were observed, but triacylglycerol concentrations decreased significantly with L-796568 treatment compared with placebo (-0.76 +/- 0.76 and 0.42 +/- 0.31 mmol/L, respectively; P < 0.002). Overall, treatment-related changes in body composition were not observed, but higher plasma L-796568 concentrations in the L-796568 group were associated with greater decreases in fat mass (r = -0.69, P < 0.03).
Conclusions: Treatment with L-796568 for 28 d had no major lipolytic or thermogenic effect but it lowered triacylglycerol concentrations. This lack of chronic effect on energy balance is likely explained by insufficient recruitment of beta(3)-responsive tissues in humans, down-regulation of the beta(3)-adrenergic receptor-mediated effects with chronic dosing, or both.
Similar articles
-
Influence of the dietary intake of medium chain triglycerides on body composition, energy expenditure and satiety: a systematic review.Nutr Hosp. 2012 Jan-Feb;27(1):103-8. doi: 10.1590/S0212-16112012000100011. Nutr Hosp. 2012. PMID: 22566308 Review.
-
Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.Metabolism. 2008 Nov;57(11):1597-607. doi: 10.1016/j.metabol.2008.06.017. Metabolism. 2008. PMID: 18940400
-
Lack of an effect of a novel beta3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study.J Clin Endocrinol Metab. 2007 Feb;92(2):527-31. doi: 10.1210/jc.2006-1740. Epub 2006 Nov 21. J Clin Endocrinol Metab. 2007. PMID: 17118998 Clinical Trial.
-
Effects of the two beta3-agonists, ZD7114 and ZD2079 on 24 hour energy expenditure and respiratory quotient in obese subjects.Int J Obes Relat Metab Disord. 2000 Dec;24(12):1553-60. doi: 10.1038/sj.ijo.0801452. Int J Obes Relat Metab Disord. 2000. PMID: 11126205 Clinical Trial.
-
Thermogenic effects of various beta-adrenoceptor agonists in humans: their potential usefulness in the treatment of obesity.Am J Clin Nutr. 1992 Jan;55(1 Suppl):249S-251S. doi: 10.1093/ajcn/55.1.249s. Am J Clin Nutr. 1992. PMID: 1345888 Review.
Cited by
-
Exercise Alleviates Aging of Adipose Tissue through Adipokine Regulation.Metabolites. 2024 Feb 22;14(3):135. doi: 10.3390/metabo14030135. Metabolites. 2024. PMID: 38535295 Free PMC article. Review.
-
Adipose tissue inflammation linked to obesity: A review of current understanding, therapies and relevance of phyto-therapeutics.Heliyon. 2023 Dec 2;10(1):e23114. doi: 10.1016/j.heliyon.2023.e23114. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38163110 Free PMC article. Review.
-
Is the β3-Adrenoceptor a Valid Target for the Treatment of Obesity and/or Type 2 Diabetes?Biomolecules. 2023 Nov 28;13(12):1714. doi: 10.3390/biom13121714. Biomolecules. 2023. PMID: 38136585 Free PMC article. Review.
-
HDAC11 inhibition triggers bimodal thermogenic pathways to circumvent adipocyte catecholamine resistance.J Clin Invest. 2023 Oct 2;133(19):e168192. doi: 10.1172/JCI168192. J Clin Invest. 2023. PMID: 37607030 Free PMC article.
-
Single-nuclei RNA Profiling Reveals Disruption of Adipokine and Inflammatory Signaling in Adipose Tissue of Burn Patients.Ann Surg. 2023 Dec 1;278(6):e1267-e1276. doi: 10.1097/SLA.0000000000005880. Epub 2023 Apr 14. Ann Surg. 2023. PMID: 37057618
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical